Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
The discovery of immune checkpoints provided a breakthrough for cancer therapy. Immune checkpoints are inhibitory receptors that are up-regulated on chronically stimulated lymphocytes and have been shown to hinder immune responses to cancer. Monoclonal antibodies against the checkpoint molecules PD-...
Main Authors: | Irina Buckle, Camille Guillerey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4263 |
Similar Items
-
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
by: Nayoung Kim, et al.
Published: (2018-09-01) -
Control of NK Cell Activation by Immune Checkpoint Molecules
by: Asma Beldi-Ferchiou, et al.
Published: (2017-10-01) -
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy
by: Haoyu Sun, et al.
Published: (2019-10-01) -
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
by: Isobel S. Okoye, et al.
Published: (2017-09-01) -
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
by: Simona Sivori, et al.
Published: (2020-09-01)